May 24, 2024 5:00pm EDT Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Apr 22, 2024 9:00am EDT Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
Mar 28, 2024 9:00am EDT Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Dec 18, 2023 9:00am EST Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
Oct 18, 2023 9:00am EDT Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis
Sep 13, 2023 9:15am EDT Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
Sep 05, 2023 8:00am EDT Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)
Aug 30, 2023 9:00am EDT Avalon’s Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis